Results 131 to 140 of about 64,246 (253)

A Comparison between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients with Congenital Factor VII Deficiency [PDF]

open access: yes, 2015
In order to establish the efficacy and biosimilar nature of AryoSeven to NovoSeven in the treatment of congenital factor VII (FVII) deficiency, patients received either agent at 30 1/4g/kg, intravenously per week for 4 weeks, in a randomized fashion. The
Abolghasemi, H.   +16 more
core  

Activated Partial Thromboplastin Time Abnormality in Patients with Cholangiocarcinoma

open access: yesClinical and Applied Thrombosis/Hemostasis, 2004
Cholangiocarcinoma can be detected worldwide, but is most common in tropical areas where crowded living conditions and poor sanitation exist. This infection can demonstrate a wide spectrum of clinical presentations from no complaints to arrest. Similar to the other liver diseases, the activated partial thromboplastin time abnormality can be seen in ...
openaire   +2 more sources

Multiple Myeloma Presenting as Lower Gastrointestinal Bleeding: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Multiple myeloma (MM) is a malignant hematologic neoplasm that primarily affects the bone marrow and can invade other organs, leading to diverse clinical manifestations. Presentation with gastrointestinal bleeding as the initial symptom is exceptionally rare.
Ahmed Arabi   +4 more
wiley   +1 more source

Elevated Activated Partial Thromboplastin Time in the Setting of Prophylactic Unfractionated Subcutaneous Heparin Administration

open access: yesAnnals of Internal Medicine: Clinical Cases
Subcutaneous unfractionated heparin, or low–molecular-weight heparin, is commonly used for venous thromboembolism prophylaxis in hospitalized patients at increased risk for developing thrombosis.
Alexander J. Johnston   +2 more
doaj   +1 more source

Trimethoprim/Sulfamethoxazole‐Induced Systemic Toxic Epidermal Necrolysis Syndrome: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Trimethoprim/sulfamethoxazole can induce life‐threatening toxic epidermal necrolysis. Early recognition, immediate drug cessation, and multidisciplinary supportive care are critical. Even with aggressive therapy, mortality remains high, and SCORTEN score aids in prognostication.
Qing Wang, Litong Chen, Wen Ye
wiley   +1 more source

Hypoglycaemia Risk Prediction Models for Type 2 Diabetes: A Systematic Review and Meta‐Analysis

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
This systematic review and meta‐analysis evaluated existing hypoglycaemia risk prediction models for Type 2 diabetes, finding excellent pooled discrimination (AUC = 0.815) but widespread high methodological bias, highlighting the need for rigorous model optimisation and external validation.
Yiwen Wei   +3 more
wiley   +1 more source

Management of neonatal massive hemorrhage: A narrative review

open access: yes
Transfusion, EarlyView.
Cheryl S. L. Chooi   +7 more
wiley   +1 more source

Lactiplantibacillus plantarum CQPC03 Reduces Carrageenan‐Induced Thrombosis in Mice via Controlling the Flora in the Gut

open access: yesFood Science &Nutrition, Volume 14, Issue 5, May 2026.
Lactiplantibacillus plantarum CQPC03 could reduce carrageenan‐induced thrombosis in mice. ABSTRACT This investigation reports the effects of Lactiplantibacillus plantarum CQPC03 (LP‐CQPC03) on preventing thrombus formation and reducing intestinal oxidative stress and inflammation in a carrageenan‐induced mouse thrombosis model. High‐throughput 16S rRNA
Xin Zhao   +6 more
wiley   +1 more source

Hematological Changes Post-Hemo and Peritoneal Dialysis Among Renal Failure Patients in Sudan

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2008
The objective of the study was to assess the changes that occur in various hematological parameters that may occur in renal failure patients after hemo and peritoneal dialysis sessions.
Mohamed Ali Mohamed   +4 more
doaj  

INDUCTION OF TOLERANCE BY ORAL ADMINISTRATION OF FACTOR VIII AND TREATMENT OF HEMOPHILA [PDF]

open access: yes, 2011
Disclosed herein is a simple method for the treatment of antigen-deficiency diseases, by orally administering to a Subject a therapeutically effective amount of the deficient anti gen, wherein the antigen is not present in a liposome.
Alpan, Oral   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy